Gainers

• BioVie (NASDAQ:BIVI) stock increased by 15.7% to $1.55 during Wednesday's after-market session. The market value of their outstanding shares is at $7.2 million. The company's, Q4 earnings came out 4 days ago.
• GridAI Technologies (NASDAQ:GRDX) stock moved upwards by 7.84% to $4.15. The market value of their outstanding shares is at $27.3 million.
• Evaxion (NASDAQ:EVAX) stock increased by 7.3% to $3.38. The market value of their outstanding shares is at $26.2 million.
• Jin Medical International (NASDAQ:ZJYL) stock increased by 5.19% to $3.24. The company's market cap stands at $24.1 million.
• Virax Biolabs Group (NASDAQ:VRAX) stock moved upwards by 5.04% to $3.34. The company's market cap stands at $2.1 million.
• TScan Therapeutics (NASDAQ:TCRX) stock increased by 5.03% to $0.79. The market value of their outstanding shares is at $55.8 million.

Losers

• Matinas BioPharma Hldgs (AMEX:MTNB) stock decreased by 20.0% to $0.19 during Wednesday's after-market session. The company's market cap stands at $2.9 million. As per the news, the Q2 earnings report came out 4 days ago.
• Edesa Biotech (NASDAQ:EDSA) stock fell 18.27% to $4.7. The company's market cap stands at $55.0 million. The company's, Q3 earnings came out 4 days ago.
• Tenon Medical (NASDAQ:TNON) shares declined by 18.23% to $9.33. The company's market cap stands at $3.6 million. As per the news, the Q2 earnings report came out 4 days ago.
• rYojbaba (NASDAQ:RYOJ) shares declined by 11.04% to $4.11. The company's market cap stands at $54.5 million.
• AIxCrypto Hldgs (NASDAQ:AIXC) stock fell 9.81% to $1.4. The company's market cap stands at $26.7 million.
• ZeroStack (NASDAQ:ZSTK) shares fell 9.48% to $4.49. The company's market cap stands at $4.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.